- Home
- PRPL vs COEP Comparison
PRPL vs COEP Comparison
Compare PRPL & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPL
- COEP
- Stock Information
- Founded
- PRPL 2010
- COEP 2017
- Country
- PRPL United States
- COEP United States
- Employees
- PRPL N/A
- COEP N/A
- Industry
- PRPL Home Furnishings
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRPL Consumer Discretionary
- COEP Health Care
- Exchange
- PRPL Nasdaq
- COEP Nasdaq
- Market Cap
- PRPL 89.8M
- COEP 72.1M
- IPO Year
- PRPL N/A
- COEP N/A
- Fundamental
- Price
- PRPL $0.73
- COEP $13.82
- Analyst Decision
- PRPL Hold
- COEP
- Analyst Count
- PRPL 1
- COEP 0
- Target Price
- PRPL $1.00
- COEP N/A
- AVG Volume (30 Days)
- PRPL 639.4K
- COEP 28.2K
- Earning Date
- PRPL 11-04-2025
- COEP 11-10-2025
- Dividend Yield
- PRPL N/A
- COEP N/A
- EPS Growth
- PRPL N/A
- COEP N/A
- EPS
- PRPL N/A
- COEP N/A
- Revenue
- PRPL $457,012,000.00
- COEP $500,996.00
- Revenue This Year
- PRPL N/A
- COEP N/A
- Revenue Next Year
- PRPL $11.87
- COEP N/A
- P/E Ratio
- PRPL N/A
- COEP N/A
- Revenue Growth
- PRPL N/A
- COEP N/A
- 52 Week Low
- PRPL $0.56
- COEP $2.31
- 52 Week High
- PRPL $1.29
- COEP $19.19
- Technical
- Relative Strength Index (RSI)
- PRPL 41.26
- COEP 45.07
- Support Level
- PRPL $0.69
- COEP $13.65
- Resistance Level
- PRPL $0.84
- COEP $15.07
- Average True Range (ATR)
- PRPL 0.07
- COEP 0.86
- MACD
- PRPL -0.00
- COEP -0.08
- Stochastic Oscillator
- PRPL 31.96
- COEP 52.21
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.